Views & Analysis Why AI and blockchain are the solutions to developing orphan... We are in the midst of a significant shift in pharmaceutical drug development, with many leading companies focusing increasingly on orphan drugs targeted at small niche markets.
Views & Analysis Why blockchain is a dream come true for pharma researchers Researchers tend to have a genuine scientific curiosity and desire to make the world better with their discoveries.
Views & Analysis Four steps to building an innovation culture in pharma The quest for innovation is a major driving force in pharma.
Views & Analysis How blockchain will revolutionise clinical trials The risky and unpredictable nature of the clinical trial process is a major driver of high costs for pharmaceutical drugs.
Views & Analysis To unlock innovation, pharma needs to be honest about failur... Many successful leaders agree that a company’s willingness to embrace and learn from failure can unlock inn
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends